Ricevi le ultime notizie sulle azioni Virpax Pharmaceuticals con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di VRPX

Ultime notizie per

Virpax Pharmaceuticals

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals Inc

Press Releases

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

News

Stocks Under $1: PMAX PRSO ARBB KAVL to Watch in March 2025 – More Stocks Inside

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

Comments

Virpax Pharmaceuticals Notizie sulle azioni

Notizie

Ultime notizie per

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO